Developing Off The Shelf Car

Media Summary: Speaker: Meisam Naeimi, DVM, PhD In this Webinar, You Will Learn: The importance of Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, shares an update on the latest developments regarding ... John Maher, BA, MBBCh, BAO, MRCPI, MRCP, MSc, FRCPath, King's College London, London, UK, talks on the potential of ...

Developing Off The Shelf Car - Detailed Analysis & Overview

Speaker: Meisam Naeimi, DVM, PhD In this Webinar, You Will Learn: The importance of Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, shares an update on the latest developments regarding ... John Maher, BA, MBBCh, BAO, MRCPI, MRCP, MSc, FRCPath, King's College London, London, UK, talks on the potential of ... Dr Velamehr presents data at AACR about the production of chimeric antigen recombinant ( On this episode of Better Biopharma, Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D., explain how the company ... Find out what drove John McKearn, Ph.D. & CEO at Wugen, out of the lab at Pfizer and on to his quest to

안녕하세요. KOBRA 첨단바이오 연구센터입니다. 2025년 11월 17일, 서울대학교 의과대학에서는 'Double-negative T cells ... Jae Park, MD, a hematologist oncologist at Memorial Sloan Kettering Cancer Center, discusses the benefits of Stephan Grupp, MD, PhD, Children's Hospital of Philadelphia, Philadelphia, PA, discusses the potential of having " MD Anderson and Takeda Pharmaceutical Company Limited have announced an exclusive license agreement and research ... Adam Sperling, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, reflects on allogeneic and

Photo Gallery

Cell Therapy: Off-the-Shelf CAR γδT Cells Generated Using CRISPR/AAV

Developing off-the-shelf CAR T-cells to treat multiple myeloma

Generating off-the-shelf CAR-Ts with iPSCs

Developing off-the-shelf CAR T cells with stem cell libraries

Allogeneic CAR-T Therapy: Understanding This New Approach in Myeloma Immunotherapy

Developing An In Vivo CAR-T With Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D.

Off-The-Shelf CAR T-Cell Therapy?

Workshops Review] Developing Off-the-Shelf CAR-T cell Therapy Using Double-Negative T cell

Dr. Park on the Benefits of Off-the-Shelf CAR T-Cell Therapy in ALL

"Off-the-shelf" CAR-T: future prospects

MD Anderson and Takeda announce collaboration to develop off-the-shelf CAR NK-cell therapies

Challenges associated with the use of off-the-shelf CAR-T products in multiple myeloma

View Detailed Profile

Cell Therapy: Off-the-Shelf CAR γδT Cells Generated Using CRISPR/AAV

Cell Therapy: Off-the-Shelf CAR γδT Cells Generated Using CRISPR/AAV

Speaker: Meisam Naeimi, DVM, PhD In this Webinar, You Will Learn: The importance of

Developing off-the-shelf CAR T-cells to treat multiple myeloma

Developing off-the-shelf CAR T-cells to treat multiple myeloma

Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, shares an update on the latest developments regarding ...

Generating off-the-shelf CAR-Ts with iPSCs

Generating off-the-shelf CAR-Ts with iPSCs

John Maher, BA, MBBCh, BAO, MRCPI, MRCP, MSc, FRCPath, King's College London, London, UK, talks on the potential of ...

Developing off-the-shelf CAR T cells with stem cell libraries

Developing off-the-shelf CAR T cells with stem cell libraries

Dr Velamehr presents data at AACR about the production of chimeric antigen recombinant (

Allogeneic CAR-T Therapy: Understanding This New Approach in Myeloma Immunotherapy

Allogeneic CAR-T Therapy: Understanding This New Approach in Myeloma Immunotherapy

Allogeneic

Developing An In Vivo CAR-T With Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D.

Developing An In Vivo CAR-T With Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D.

On this episode of Better Biopharma, Interius BioTherapeutics' Sianny Christanti and Babu Medi, Ph.D., explain how the company ...

Off-The-Shelf CAR T-Cell Therapy?

Off-The-Shelf CAR T-Cell Therapy?

Find out what drove John McKearn, Ph.D. & CEO at Wugen, out of the lab at Pfizer and on to his quest to

Workshops Review] Developing Off-the-Shelf CAR-T cell Therapy Using Double-Negative T cell

Workshops Review] Developing Off-the-Shelf CAR-T cell Therapy Using Double-Negative T cell

안녕하세요. KOBRA 첨단바이오 연구센터입니다. 2025년 11월 17일, 서울대학교 의과대학에서는 'Double-negative T cells ...

Dr. Park on the Benefits of Off-the-Shelf CAR T-Cell Therapy in ALL

Dr. Park on the Benefits of Off-the-Shelf CAR T-Cell Therapy in ALL

Jae Park, MD, a hematologist oncologist at Memorial Sloan Kettering Cancer Center, discusses the benefits of

"Off-the-shelf" CAR-T: future prospects

"Off-the-shelf" CAR-T: future prospects

Stephan Grupp, MD, PhD, Children's Hospital of Philadelphia, Philadelphia, PA, discusses the potential of having "

MD Anderson and Takeda announce collaboration to develop off-the-shelf CAR NK-cell therapies

MD Anderson and Takeda announce collaboration to develop off-the-shelf CAR NK-cell therapies

MD Anderson and Takeda Pharmaceutical Company Limited have announced an exclusive license agreement and research ...

Challenges associated with the use of off-the-shelf CAR-T products in multiple myeloma

Challenges associated with the use of off-the-shelf CAR-T products in multiple myeloma

Adam Sperling, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, reflects on allogeneic and

Building "Off-the-Shelf" CAR T-cells - Sidharth Raghavan

Building "Off-the-Shelf" CAR T-cells - Sidharth Raghavan

Sidharth presents on Building "